Work

Combining enzalutamide with PARP inhibitors: Pharmaceutically induced BRCAness

Year: 2017

Type: article

Source: Oncotarget

DOI: 10.18632/oncotarget.22074

Authors: Timothy C. Thompson, Likun Li, Bradley M. Broom

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funder: National Cancer Institute

Award: MD Anderson Cancer Center Prostate Cancer SPORE

OpenAlex ID: W2765894386

FWCI: 0.215

Cites: 8

Cited by: 8

Related to: 10